SSTR2 and neuroendocrine neoplasm: ♂ Somatostatin receptors, especially subtype 2 (SST2 according to the current nomenclature [1], formerly abbreviated as SSTR2 or SSTR2 or sstr2), are expressed in high incidence and density in neuroendocrine tumour cells.